The ACTC1 Gene Atrial Septal Defect Type 5 NGS Genetic DNA Test is crucial for identifying genetic predispositions to atrial septal defects.this test utilizes advanced NGS technology to provide insights into cardiovascular health. It is recommended for individuals with a family history of heart defects or those experiencing related symptoms. With a turnaround time of 3 to 4 weeks, the test helps in understanding potential risks and informs future medical decisions.
